Jubilant Life Sciences to set up new plant in Gujarat

(JLS) today said it is setting up a manufacturing plant to produce Symtet, a key ingredient for making insecticide 'Chlorpyrifos', at Bharuch in Gujarat, as part of its nearly Rs 350 crore plans for the next fiscal.

JLS will set up a manufacturing plant in the Special Economic Zone, at Bharuch, for the chemical commercially known as Symtet/TCP, which will have a capacity of 24,000 tonne per annum (TPA), it said in a statement.

The new plant will also manufacture chlorinated pyridine derivatives with an annual production of 5,000 tonne, it added.

"The company has earmarked Rs 350 crore for in 2011-12. The new project in Gujarat would be a part of this capacity expansion," JLS Executive Director Finance R Sankaraiah told PTI.

The company, however, did not disclose the investment details of the project.

The facility, which is expected to be operational from the fourth quarter of FY 2012, will make Jubilant the largest producer of Symtet globally catering to more than 40% of the worldwide demand, the company said.

JLS has received approvals from major customers and is in the process of firming up long-term arrangements with them. It expects to achieve additional annual revenue of $90 million from this facility, it added.

"Jubilant will be the only company in the world manufacturing Symtet through this environment friendly technology, developed by inhouse R&D having complete backward integration up to the basic feed stock," JLS CMD Shyam S Bhartia and Co-Chairman and MD Hari S Bhartia said.

Shares of today closed at Rs 165.70 on the Bombay Stock Exchange, up 1.41% from its previous close.

image
Business Standard
177 22
Business Standard

Jubilant Life Sciences to set up new plant in Gujarat

Press Trust of India  |  New Delhi 

Pharma

(JLS) today said it is setting up a manufacturing plant to produce Symtet, a key ingredient for making insecticide 'Chlorpyrifos', at Bharuch in Gujarat, as part of its nearly Rs 350 crore plans for the next fiscal.

JLS will set up a manufacturing plant in the Special Economic Zone, at Bharuch, for the chemical commercially known as Symtet/TCP, which will have a capacity of 24,000 tonne per annum (TPA), it said in a statement.

The new plant will also manufacture chlorinated pyridine derivatives with an annual production of 5,000 tonne, it added.

"The company has earmarked Rs 350 crore for in 2011-12. The new project in Gujarat would be a part of this capacity expansion," JLS Executive Director Finance R Sankaraiah told PTI.

The company, however, did not disclose the investment details of the project.

The facility, which is expected to be operational from the fourth quarter of FY 2012, will make Jubilant the largest producer of Symtet globally catering to more than 40% of the worldwide demand, the company said.

JLS has received approvals from major customers and is in the process of firming up long-term arrangements with them. It expects to achieve additional annual revenue of $90 million from this facility, it added.

"Jubilant will be the only company in the world manufacturing Symtet through this environment friendly technology, developed by inhouse R&D having complete backward integration up to the basic feed stock," JLS CMD Shyam S Bhartia and Co-Chairman and MD Hari S Bhartia said.

Shares of today closed at Rs 165.70 on the Bombay Stock Exchange, up 1.41% from its previous close.

RECOMMENDED FOR YOU

Jubilant Life Sciences to set up new plant in Gujarat

Jubilant Life Sciences (JLS) today said it is setting up a manufacturing plant to produce Symtet, a key ingredient for making insecticide 'Chlorpyrifos', at Bharuch in Gujarat, as part of its nearly Rs 350 crore capacity expansion plans for the next fiscal.

(JLS) today said it is setting up a manufacturing plant to produce Symtet, a key ingredient for making insecticide 'Chlorpyrifos', at Bharuch in Gujarat, as part of its nearly Rs 350 crore plans for the next fiscal.

JLS will set up a manufacturing plant in the Special Economic Zone, at Bharuch, for the chemical commercially known as Symtet/TCP, which will have a capacity of 24,000 tonne per annum (TPA), it said in a statement.

The new plant will also manufacture chlorinated pyridine derivatives with an annual production of 5,000 tonne, it added.

"The company has earmarked Rs 350 crore for in 2011-12. The new project in Gujarat would be a part of this capacity expansion," JLS Executive Director Finance R Sankaraiah told PTI.

The company, however, did not disclose the investment details of the project.

The facility, which is expected to be operational from the fourth quarter of FY 2012, will make Jubilant the largest producer of Symtet globally catering to more than 40% of the worldwide demand, the company said.

JLS has received approvals from major customers and is in the process of firming up long-term arrangements with them. It expects to achieve additional annual revenue of $90 million from this facility, it added.

"Jubilant will be the only company in the world manufacturing Symtet through this environment friendly technology, developed by inhouse R&D having complete backward integration up to the basic feed stock," JLS CMD Shyam S Bhartia and Co-Chairman and MD Hari S Bhartia said.

Shares of today closed at Rs 165.70 on the Bombay Stock Exchange, up 1.41% from its previous close.

image
Business Standard
177 22

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard